Listing a study does not mean it has been evaluated by the U. Hydroxychloroquine (Plaquenil) is considered a disease-modifying anti-rheumatic drug (DMARD). Quinacrine with hydroxychloroquine lupus profundus Chad hummel ophthalmologist plaquenil Efficacy and Safety of Hydroxychloroquine for Treatment of Pneumonia Caused by 2019-nCoV HC-nCoV The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U. S. Federal Government. Hydroxychloroquine Plaquenil is a drug that is classified as an anti-malarial drug. Plaquenil is prescribed for the treatment or prevention of malaria. It is also prescribed for the treatment of rheumatoid arthritis, lupus, and the side effects of lupus such as hair loss, joint pain, and more. The 10-2 HVF with red stimulus was touted as the testing strategy of choice due to its 91% sensitivity for detection of Plaquenil toxicity; however, there is only a 57% specificity. 18 On the converse, the 10-2 white stimulus testing strategy has a lower sensitivity of 78%, but it has a better specificity of 84%. It may prevent joint damage and reduce the risk of long-term disability. It can decrease the pain and swelling of arthritis. Hydroxychloroquine testing Hydroxychloroquine Blood Levels in SLE Clarifying dosing., Hydroxychloroquine Plaquenil Side Effects & Dosage for Malaria Different brands of hydroxychloroquineRa plaquenil success ratesDoes plaquenil relieve fibromyalgia or psoriatic arthritis The American Academy of Ophthalmology released an updated set of screening recommendations for hydroxychloroquine Plaquenil and chloroquine to account for the many studies that have shown the effects of these medications on the retina 1. It succinctly makes the case for screening, and Hydroxychloroquine And Chloroquine Screening 2016 AAO.. How to Succeed in Plaquenil Screenings. Hydroxychloroquine Plaquenil Toxicity and Recommendations.. This article is from June 2011 and may contain outdated material. Download PDF. Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy Retinal toxicity from chloroquine CQ and its analogue, hydroxychloroquine HCQ, has been recognized for many years. Chloroquine toxicity remains a problem in many parts of the world, but is seen less frequently in the United States where the drug largely has been replaced by HCQ. Safety and efficacy of hydroxychloroquine to treat lupus and arthritis have not been established in children. Geriatric. Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of hydroxychloroquine in the elderly.